Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00345696
Status:
COMPLETED
Last Update Posted:
2011-08-24
First Post:
2006-06-27
Brief Title:
1stline Study Capecitabine Administered on Continuous Way Plus OxaliplatinBevacizumab Every 2weeks in Metastatic CCR
Sponsor:
Organization:
Unidad Integral de Investigación en Oncología SL